RECRUITING

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Although global efforts have been made to end the HIV epidemic, there are still some gaps in HIV testing, antiretroviral therapy (ART) adherence, and viral suppression (VS) among people with HIV (PWH). These gaps are particularly prominent in the Deep South of the United States (US), where PWH face challenges in accessing healthcare services. In response, a team of experienced researchers has developed and tested the Community Health Workers And MHealth to ImProve Viral Suppression (CHAMPS) intervention. This intervention uses mobile health (mHealth) technology and a team of community health workers (CHW) to design an intervention to improve ART adherence and VS. The CHAMPS+ intervention adds a CHW delivered supportive risk reduction counseling during periods of non-suppression to prevent HIV transmission. The study will engage the participants by developing culturally relevant materials and retention strategies, evaluating the clinical effectiveness and sustainability of the intervention in Deep South settings, and assessing regionalized implementation factors. Ultimately, the study will test the effectiveness of CHAMPS+ on ART adherence and viral load suppression for PWH in Alabama, Louisiana, and Mississippi.

Official Title

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

Quick Facts

Study Start:2024-09-23
Study Completion:2027-12-22
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06472206

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Be able to speak, read, and write in English;
  2. * Be above 18 years of age;
  3. * Be willing to participate in any assigned arm of the intervention;
  4. * Have an HIV-1 RNA level \>200 copies/mL;
  5. * Own a smartphone;
  6. * Be able and willing to provide informed consent for study participation and consent for access to medical records.
  7. * Live, work and or receive care in AL, LA, or MS
  1. * Have been diagnosed with HIV ≤3 months ago;
  2. * Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment;
  3. * Terminal illness with life expectancy \<6 months; and
  4. * Planning to move out of the area in the next 12 months.

Contacts and Locations

Study Contact

Rebecca Schnall, PhD, MPH
CONTACT
212-342-6886
rb897@columbia.edu
Zoe Brown
CONTACT
212-305-3634
zb2350@cumc.columbia.edu

Principal Investigator

Rebecca Schnall, PhD, MPH
PRINCIPAL_INVESTIGATOR
Columbia University
Scott Batey, PhD, MSW
PRINCIPAL_INVESTIGATOR
Tulane University

Study Locations (Sites)

Health Services Center, Inc.
Hobson City, Alabama, 36202
United States
Unity Wellness Center
Opelika, Alabama, 36801
United States
Louisiana State University Health Sciences Center in New Orleans
New Orleans, Louisiana, 70112
United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Rebecca Schnall, PhD, MPH, PRINCIPAL_INVESTIGATOR, Columbia University
  • Scott Batey, PhD, MSW, PRINCIPAL_INVESTIGATOR, Tulane University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-23
Study Completion Date2027-12-22

Study Record Updates

Study Start Date2024-09-23
Study Completion Date2027-12-22

Terms related to this study

Additional Relevant MeSH Terms

  • HIV/AIDS